A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...
Animate Biosciences today announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that ...
Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...
CDK2 molecular glue degrader MRT-51443 shows enhanced tumor regression and delayed resistance in breast cancer models, surpassing standard treatments. Details regarding the clinical development ...
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 5, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), ...
Nurix Therapeutics, Inc. presented promising preclinical data at the AACR 2025 Annual Meeting, showcasing their innovative targeted protein degradation medicines aimed at addressing various cancers, ...
The Swiss healthtech startup’s patented multi-tissue platform is designed to improve the speed, safety, and human relevance ...
Well before a human receives the first dose of an experimental drug, it’s evaluated in an animal to test for toxicity. Monkeys are often chosen for their genetic similarities to humans, and safe ...
Machine-learning–guided screening identified a structurally novel NK1 receptor antagonist that reduced depressive-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback